Tosoh Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 6, 2012 39 Pages - SKU: ICDR6792507 |
| Synopsis ICD Research's Tosoh Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Tosoh Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Tosoh Corporation. ICD Research's Tosoh Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Tosoh Corporation (Tosoh) is a producer of caustic soda and soda ash in Japan. The company supplies inorganic chemicals, petrochemicals and specialty materials globally. Tosoh, along with its subsidiaries, serves semiconductor, pharmaceutical, health care and food, and many other related industries. It is also into the development of products and provision of services in the field of water purification and environment monitoring. Tosoh Group constitutes 112 subsidiaries and 20 affiliate companies across Japan, and remaining in the US, Europe, and Asia Pacific including China, Indonesia, Philippines, Republic of Korea and Singapore; apart from the parent company Tosoh Corporation. Tosoh is headquartered in Tokyo, Japan. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

